Among these, manipulation of BCG to secrete Th1 cytokines (e.g., IL-2, IL-18, IFN-γ, and IFN-α), alone or in combination with coexpression of bacterial or tumor antigens, represents one of the most attractive strategies for the development of improved vaccines. Here, IL2 is linked to neoplasm.